Search
for
Sort by
Research 601–630 of 1000+
- The Case Report on the Effectiveness of Infrared Light on Acid Burn Victim
- Subject Index
- The JAK/STAT signaling pathway: from bench to clinic
- Chemical Composition and Biological Activities of Essential Oils of Curcuma Species
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- Update on hidradenitis suppurativa: connecting the tracts
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- “A thing of beauty is a joy forever”. Plants and plant-based preparations for facial care in Suriname
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Spectrum and Impact of Reported Side Effects of Omalizumab in Patients With Chronic Urticaria: A Long‐Term Multicentre Real‐World Study
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Vitiligo—Current Treatment Options and Future Perspectives
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- The patient journey in prurigo nodularis: what lies ahead
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Light exposure and its applications in human health
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Heterozygous FOXN1 Variants Cause Low TRECs and Severe T Cell Lymphopenia, Revealing a Crucial Role of FOXN1 in Supporting Early Thymopoiesis
- Current Advanced Therapies Based on Human Mesenchymal Stem Cells for Skin Diseases
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- The most recent advances in understanding and managing hidradenitis suppurativa
- The Implication of Neuroactive Steroids in Tourette's Syndrome Pathogenesis: A Role for 5α‐Reductase?
- Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases